Xultophy Injection: A Comprehensive Solution for Diabetes Management

Xultophy Injection combines the power of two essential medications in a single vial: liraglutide (3.6mg/1ml) and insulin degludec (100IU). This unique formulation offers comprehensive management of type 2 diabetes, allowing you to achieve optimal blood sugar control with greater ease and convenience.

Xultophy:
* Liraglutide (an GLP-1 receptor agonist): Increases insulin release, while also decreasing glucagon production, helping to lower blood glucose levels.
* Insulin Degludec (a long-acting insulin analog): Provides continuous, extended-duration insulin action, making it ideal for managing day-to-day fluctuations in blood sugar.

The combination of these medications creates a powerful and sustained effect, providing improved glycemic control with minimal daily adjustments compared to traditional insulin therapy. Xultophy is indicated for use in adults with type 2 diabetes who require basal-bolus insulin regimens for treatment and self-management.

Note: Please consult your healthcare provider before starting or changing any medical treatment plan.